Buscar resultados de ensayos clínicos
Nut Hypersensitivity - 32 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy Condición:
|
| Active, not recruiting |
Nombre del estudio: Peanut Oral Immunotherapy in Children Condición: Peanut Hypersensitivity Fecha: 2013-05-23 Intervenciones:
|
| Completed |
Nombre del estudio: Epicutaneous Immunotherapy in Peanut Allergy in Children Condición: Peanut Allergy Fecha: 2010-09-07 Intervenciones:
|
| Completed |
Nombre del estudio: Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization Condición: Peanut Allergies in Children Fecha: 2012-06-19 Intervenciones: Drug: Ketotifen titrated dose: 1 mg once a day, then 1 mg twice a day then 2 mg twice a day |
| Completed |
Nombre del estudio: PALISADE Follow-on Study (ARC004) Condición: Peanut Allergy Fecha: 2016-12-08 Intervenciones: Biological: AR101 AR101 powder provided in capsules & sachets |
| Active, not recruiting |
Nombre del estudio: Oral Peanut Immunotherapy Condición: Peanut Allergy Fecha: 2010-08-12 Intervenciones: Drug: Peanut flour OIT Patients will receive daily escalating dosages as determined in the modified rush |
| Enrolling by invitation |
Nombre del estudio: Identification of Anaphylactogenic Antibodies in Peanut Allergy Condición: Peanut Allergy Fecha: 2016-06-29 Intervenciones: Other: Observational study Blood sampling |
| Active, not recruiting |
Nombre del estudio: Safety Study of Viaskin Peanut to Treat Peanut Allergy Condición: Peanut Allergy Fecha: 2016-09-26 Intervenciones:
|
| Active, not recruiting |
Nombre del estudio: Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy Condición: Peanut Allergy Fecha: 2013-11-28 Intervenciones: Drug: Omalizumab Omalizumab is the treatment during oral immunotherapy with peanuts as protection |
| Active, not recruiting |
Nombre del estudio: Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy Condición: Peanut Allergy Fecha: 2015-11-19 Intervenciones:
|